Application of locked nucleic acids to improve aptamer in vivo stability and targeting function

被引:239
作者
Schmidt, KS
Borkowski, S
Kurreck, J
Stephens, AW
Bald, R
Hecht, M
Friebe, M
Dinkelborg, L
Erdmann, VA
机构
[1] Free Univ Berlin, Inst Chem Biochem, D-14195 Berlin, Germany
[2] Schering AG, Res Labs, D-13342 Berlin, Germany
关键词
D O I
10.1093/nar/gkh862
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aptamers are powerful candidates for molecular imaging applications due to a number of attractive features, including rapid blood clearance and tumor penetration. We carried out structure-activity relationship (SAR) studies with the Tenascin-C binding aptamer TTA1, which is a promising candidate for application in tumor imaging with radioisotopes. The aim was to improve its in vivo stability and target binding. We investigated the effect of thermal stabilization of the presumed non-binding double-stranded stem region on binding affinity and resistance against nucleolytic degradation. To achieve maximal thermal stem stabilization melting experiments with model hexanucleotide duplexes consisting of unmodified RNA, 2'-O-methyl RNA (2'-OMe), 2'-Fluoro RNA (2'-F) or Locked Nucleic Acids (LNAs) were initially carried out. Extremely high melting temperatures have been found for an LNA/LNA duplex. TTA1 derivatives with LNA and 2'-OMe modifications within the non-binding stem have subsequently been synthesized. Especially, the LNA-modified TTA1 derivative exhibited significant stem stabilization and markedly improved plasma stability while maintaining its binding affinity to the target. In addition, higher tumor uptake and longer blood retention was found in tumor-bearing nude mice. Thus, our strategy to introduce LNA modifications after the selection procedure is likely to be generally applicable to improve the in vivo stability of aptamers without compromising their binding properties.
引用
收藏
页码:5757 / 5765
页数:9
相关论文
共 45 条
[1]   Intramolecular G-quartet motifs confer nuclease resistance to a potent anti-HIV oligonucleotide [J].
Bishop, JS ;
GuyCaffey, JK ;
Ojwang, JO ;
Smith, SR ;
Hogan, ME ;
Cossum, PA ;
Rando, RF ;
Chaudhary, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (10) :5698-5703
[2]   Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA [J].
Braasch, DA ;
Corey, DR .
CHEMISTRY & BIOLOGY, 2001, 8 (01) :1-7
[3]   In vivo imaging of inflammation using an aptamer inhibitor of human neutrophil elastase [J].
Charlton, J ;
Sennello, J ;
Smith, D .
CHEMISTRY & BIOLOGY, 1997, 4 (11) :809-816
[4]   Design and characterization of decoy oligonucleotides containing locked nucleic acids [J].
Crinelli, R ;
Bianchi, M ;
Gentilini, L ;
Magnani, M .
NUCLEIC ACIDS RESEARCH, 2002, 30 (11) :2435-2443
[5]   A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment [J].
Daniels, DA ;
Chen, H ;
Hicke, BJ ;
Swiderek, KM ;
Gold, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (26) :15416-15421
[6]   LNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1 [J].
Darfeuille, F ;
Hansen, JB ;
Orum, H ;
Primo, CD ;
Toulmé, JJ .
NUCLEIC ACIDS RESEARCH, 2004, 32 (10) :3101-3107
[7]   Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys [J].
Drolet, DW ;
Nelson, J ;
Tucker, CE ;
Zack, PM ;
Nixon, K ;
Bolin, R ;
Judkins, MB ;
Farmer, JA ;
Wolf, JL ;
Gill, SC ;
Bendele, RA .
PHARMACEUTICAL RESEARCH, 2000, 17 (12) :1503-1510
[8]   LETS GET SPECIFIC - THE RELATIONSHIP BETWEEN SPECIFICITY AND AFFINITY [J].
EATON, BE ;
GOLD, L ;
ZICHI, DA .
CHEMISTRY & BIOLOGY, 1995, 2 (10) :633-638
[9]  
Eder P S, 1991, Antisense Res Dev, V1, P141
[10]   INVITRO SELECTION OF RNA MOLECULES THAT BIND SPECIFIC LIGANDS [J].
ELLINGTON, AD ;
SZOSTAK, JW .
NATURE, 1990, 346 (6287) :818-822